期刊文献+

补体系统调节蛋白H因子家族异常与肾脏疾病 被引量:2

Abnormal complement H factor family and kidney diseases
下载PDF
导出
摘要 H因子(FH)家族是补体激活旁路途经的调节蛋白,非典型溶血性尿毒综合征、C3肾小球肾炎、致密物沉积病、IgA肾病、狼疮性肾炎等肾脏疾病均与之相关。遗传学研究提示FH家族在疾病的发生发展中具有重要作用。临床和功能学研究证实了基因突变导致的FH家族蛋白结构和浓度的改变影响补体旁路途径的激活。研究也促进了FH家族在疾病诊断与治疗上的应用。本文旨在对FH家族异常致肾脏疾病的研究进行综述并介绍其诊断与治疗上的进展,希望能为进一步的研究提供参考。 The H factor family is a regulatory protein for complement alternative pathway.The pathogenesis and progression of a variety of kidney diseases are related to H factor family,such as atypical hemolytic uremic syndrome,C3 glomerulonephritis,dense deposit disease,IgA nephropathy,lupus nephritis,etc.Genetic studies suggest that H factor family plays an important role in occurrence and development of some kidney diseases.Clinical and functional studies have confirmed that,structure and concentration of factor H family proteins affect the activation of alternative complement pathway.Studies also promote the application of factor H family in disease diagnosis and treatment.This article reviews the influence of factor H family on diseases and introduces the progress of diagnosis and treatment.
作者 铁丰红(综述) 于磊(审校) TIE Fenghong;YU Lei(Department of Nephrology,Xing'an League people's hospital,Ulanhot 137400,China;Department of Nephrology,Inner Mongolia people's hospital,Hohhot 010017,China)
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 北大核心 2020年第5期464-468,共5页 Chinese Journal of Nephrology,Dialysis & Transplantation
基金 国家自然科学基金(81160087) 国家自然科学基金(816-60117) 内蒙古自治区自然科学基金(2018MS08008) 内蒙古自治区科技计划项目(201502107)
关键词 H因子 肾脏疾病 遗传学 发病机制 factor H nephropathy pathogenesis genetics
  • 相关文献

参考文献2

二级参考文献29

  • 1Fakhouri F, Fremeaux-Bacchi V, Noel LH, et al. C3 glomerulopathy: a new classification. Nat Rev Nephrol,2010,6 (8) :494 -499. 被引量:1
  • 2Servais A, Fremeaux-Bacchi V, Lequintrec M, et al. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med C, enet,2007,44 ( 3 ), 193 - 199. 被引量:1
  • 3Alchi B, Jayne D. Membranoproliferative glomerulonephritis. Pediatr Nephrol,2010,25 (8) : 1409 - 1415. 被引量:1
  • 4Habib R, Gubler MC, Loirat C, et al. Dense deposit disease : a variant of membranoproliferative glomerulonephritis. Kidney Int, 1975,7 (4) : 204 -215. 被引量:1
  • 5Churg J, Duffy JL, Bernstein J. Identification of dense deposit disease : a report for the International Study of Kidney Diseases in Children. Arch Pathol Lab Med, 1979,103 ( 2 ) :67 - 72. 被引量:1
  • 6Nakopoulou L. Membranoproliferative glomerulonephritis. Nephrol Dial Transplant,2001,16 ( Suppl 6) :71 - 73. 被引量:1
  • 7Walker PD, Ferrario F, Joh K, et al. Dense deposit disease is not a membranoproliferative glomerulonephritis. Mod Pathol, 2007,20 : 605-616. 被引量:1
  • 8Levy M, Gubler MC, Sich M, et al. Immunopathology of membranoproliferative glomerulonephritis with subendothelial deposits (type I MpGN). Clin Immunol Immunopathol, 1978,10 (4) :477 - 492. 被引量:1
  • 9Lachmann PJ. The amplification loop of the complement pathways. Adv Immuno1,2009,104 : 115 - 149. 被引量:1
  • 10Licht C, Fremeaux-Bacchi V. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis. Thromb Haemost,2009,101 (2) :271 - 278. 被引量:1

共引文献6

同被引文献19

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部